The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Zaidieva Ya.Z.
Moscow Regional Research Institute of Obstetrics and Gynecology
Balan V.E.
Moscow Regional Scientific Research Institute of Obstetrics and Gynecology
Tsar’kova A.V.
Moscow Regional Research Institute of Obstetrics and Gynecology
Relationship between adipocytes and androgens — the cause of comorbidities in women with polycystic ovary syndrome
Journal: Russian Bulletin of Obstetrician-Gynecologist. 2023;23(6): 25‑33
Read: 1302 times
To cite this article:
Zaidieva YaZ, Balan VE, Tsar’kova AV. Relationship between adipocytes and androgens — the cause of comorbidities in women with polycystic ovary syndrome. Russian Bulletin of Obstetrician-Gynecologist.
2023;23(6):25‑33. (In Russ.)
https://doi.org/10.17116/rosakush20232306125
The review presents the current knowledge about the relationship between androgens and adipocytes in women with polycystic ovary syndrome. Adipocytes are actively involved in steroid metabolism. The conversion of «weak» androgens to «strong» androgens takes place in them. In addition, adipocytes modulate ovarian production of testosterone and androstenedione through the action of various adipocytokines. Androgens also participate in the proliferation and differentiation of adipocytes, stimulate the secretion of adipocytokines and promote the accumulation of visceral adipose tissue. Androgens cause hypertrophy of adipocytes and contribute to the formation of insulin resistance in these cells. Androgens are known to increase insulin secretion by β-cells. Insulin, in turn, affects ovarian theca cells, leading to increased secretion of androgens. The described pathophysiological mechanisms contribute to the development of associated diseases and pathological conditions such as dyslipidemia, chronic inflammation of low intensity, non-alcoholic fatty liver disease, metabolic syndrome, type 2 diabetes mellitus, arterial hypertension and other cardiovascular diseases.
Authors:
Zaidieva Ya.Z.
Moscow Regional Research Institute of Obstetrics and Gynecology
Balan V.E.
Moscow Regional Scientific Research Institute of Obstetrics and Gynecology
Tsar’kova A.V.
Moscow Regional Research Institute of Obstetrics and Gynecology
Received:
24.11.2022
Accepted:
20.12.2022
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.